Smoldering Multiple MyelomaSymptoms, Doctors, Treatments, Advances & More
Learn About Smoldering Multiple Myeloma
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Dana-Farber Cancer Institute, Lipper Multiple Myeloma Center
Jacob Laubach is an Oncologist and a Hematologist practicing medicine in Boston, Massachusetts. Dr. Laubach is rated as an Elite provider by MediFind in the treatment of Smoldering Multiple Myeloma. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Smoldering Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Laubach is board certified in Hematology, Internal Medicine, and Medical Oncology.
Dana-Farber Cancer Institute, Lipper Multiple Myeloma Center
Nikhil Munshi is an Oncologist practicing medicine in Boston, Massachusetts. Dr. Munshi is rated as an Elite provider by MediFind in the treatment of Smoldering Multiple Myeloma. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Smoldering Multiple Myeloma, Castleman Disease, and Relapsed Refractory Multiple Myeloma (RRMM). Dr. Munshi is board certified in Internal Medicine and Medical Oncology.
Emory Winship Cancer Institute
Sagar Lonial is a Hematologist Oncology provider practicing medicine in Atlanta, Georgia. He has been practicing medicine for over 33 years. Dr. Lonial is rated as an Elite provider by MediFind in the treatment of Smoldering Multiple Myeloma. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Smoldering Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Aplastic Anemia, and Bone Marrow Transplant. Dr. Lonial is board certified in American Board Of Internal Medicine, 2000.
Summary: The goal of this study is to find markers that may help to predict why some patients who have monoclonal gammopathy of unknown significance (MGUS) or smoldering multiple myeloma (SMM) that have no signs or symptoms of disease (asymptomatic) develop multiple myeloma, while others do not. Studying markers such as age, level of proteins in blood, percent of abnormal blood cells in the bone marrow, ge...
Summary: The researchers are doing this study to look at how butyrate levels change in participants' stool after they are on a- plant-based diet for at least 12 weeks. All participants will have monoclonal gammopathy of undetermined significance (MGUS) or smoldering multiple myeloma (SMM). We will compare how the plant-based diet, omega-3 fatty acid and curcumin supplements, and placebo (an inactive substa...